Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1418 of 5804
-
New hope for hunter syndrome: Long-Term drug trial launches
Disease control ENROLLING_BY_INVITATIONThis is a multiregional open-label extension (OLE) to assess the safety, tolerability, and efficacy of long-term treatment with tividenofusp alfa (DNL310), an investigational central nervous system (CNS)-penetrant intravenous (IV) enzyme replacement therapy (ERT) for Hunter syndr…
Phase: PHASE2, PHASE3 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Could a gut bacteria transplant ease autism symptoms? new trial aims to find out
Disease control Recruiting nowAutism Spectrum Disorder (ASD) is a group of serious neurodevelopmental disorders. A significant comorbidity exists between ADHD and ASD: 30%-50% of individuals with ASD exhibit ADHD symptoms, and two-thirds with ADHD show ASD traits. Intestinal microbial disturbance is common in…
Phase: PHASE1 • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Jun 26, 2026 14:01 UTC
-
New depression drug shows promise in large trial
Symptom relief CompletedThis is a randomized, double blind, placebo controlled, multi-center study to evaluate the effects of NMRA-335140 (formerly BTRX 335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 28 days)…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control CompletedThe purpose of this trial is to test different doses of the trial medicine (LEO 138559) and see how well they work and how safe they are at treating moderate to severe atopic dermatitis in adults. There will be 4 different doses, that will also be compared to a placebo (a dummy m…
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New device catches debris during heart valve procedure to protect the brain
Disease control CompletedTo evaluate the safety and effectiveness of the Cerebral Protection System (model CEP016F, Shanghai Shenqi Medical Technology Co., Ltd.) for capturing and removing thrombotic and tissue debris during transcatheter aortic valve replacement (TAVR).
Phase: NA • Sponsor: Shanghai Shenqi Medical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New cocktail shows promise against tough rectal tumors
Disease control CompletedIt is a single-center, retrospective, controlled study to investigate the efficacy and safety of neoadjuvant chemoradiotherapy combined with PD-1 inhibitor and thymalfasin for locally advanced mid-low rectal cancer.
Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy targets post-concussion depression in veterans and civilians
Symptom relief Recruiting nowThe primary goal of this clinical trial is to evaluate whether Personalized Augmented Cognitive Training (PACT) plus intermittent theta burst stimulation (iTBS) is effective for treating depression in Service Members, Veterans, and civilians who have sustained a mild TBI. Partici…
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New test combo could slash unnecessary antibiotic use in sepsis
Knowledge-focused OngoingMODIFY is a randomized, open-labeled, and prospective study that will be conducted in multiple Intensive Care Units (ICUs) and departments of Internal Medicine across Greece. It aims to change the traditional approach for the management of severe infections by integrating the res…
Phase: PHASE3 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New program aims to help families in war zones cope and thrive
Knowledge-focused Recruiting nowFew evidence-based programs exist to support children and families affected by sociopolitical conflict, despite documented evidence of their heightened risk for emotional and behavioral adjustment problems associated with exposure to conflict and violence at multiple levels of th…
Phase: NA • Sponsor: University of Notre Dame • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Shockwaves vs. sham: new hope for ED and pelvic pain?
Symptom relief Recruiting nowThe purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Job help plus HIV prevention: a new approach for At-Risk youth
Prevention Recruiting nowThe study team will conduct a two-group study to examine the efficacy of implementing a combination intervention to improve economic stability and HIV preventive behaviors. The team will enroll approximately 500 young adults. Participants will be randomly assigned to one of two g…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New glasses could slow Kids' worsening eyesight
Disease control Recruiting nowThis is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy. This is a randomized, controlled (1:1), multisite, subject- and observer-masked,…
Phase: NA • Sponsor: SightGlass Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Hypnosis therapy shows promise for spinal cord injury pain relief
Symptom relief OngoingChronic spinal cord injury (SCI) pain is complex and difficult to treat. For individuals with SCI, pain often begins early in the course of their SCI and continues longitudinally. Unfortunately, SCI-related pain is frequently not responsive to medical treatment and medical treatm…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New device aims to catch surgical debris, prevent stroke and kidney damage
Disease control Recruiting nowThis is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Glow-in-the-Dark dyes could catch esophageal cancer earlier
Diagnosis Recruiting nowPrevious studies have confirmed the great potential of quantitative fluorescence molecular endoscopy (qFME) when looking at additional lesion detection initially missed by high-definition white light endoscopy (HD-WLE) for surveillance of Barrett's esophagus.
Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
New obesity injection shows promise in early trial
Disease control CompletedThe purpose of the study is to evaluate if a new study drug, NNC0487-0111, is safe and how it works in the participant's body, when given as injections under the skin
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could diabetes drugs also protect kidneys by fixing fat?
Disease control Recruiting nowChronic kidney disease (CKD) is the progressive damage to kidney function, associated with an increased risk of cardiovascular diseases, such as stroke or myocardial infarct, particularly in the most severe stages of CKD, in which the patient requires dialysis. Several risk facto…
Sponsor: Cardenal Herrera University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Ovarian cancer drug combo trial halted early – what we know
Disease control TerminatedThis is a Phase 1b/2a, open-label, adaptive-design outpatient study to assess the safety, tolerability, and PK/PD of SON-1010 in combination with atezolizumab administered to patients with advanced solid tumors (Part 1) and patients with Platinum-resistant Ovarian Cancer (Part 2)
Phase: PHASE1, PHASE2 • Sponsor: Sonnet BioTherapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo could delay painful mouth sores in cancer radiation
Symptom relief CompletedThe goal of this study is to compare glutamine combined with thalidomide with glutamine in preventing radiation-induced oral mucositis. The aim of this study is to answer whether glutamine plus thalidomide could improve the median incidence time of grade 2 oral mucositis. Partici…
Phase: PHASE3 • Sponsor: Air Force Military Medical University, China • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Experimental combo aims to outsmart resistant lung cancer
Disease control Recruiting nowThe purpose of this study is to examine the combination of osimertinib and carotuximab to assess the safety and find the recommended dose for treatment of advanced EGFR-mutated non-small cell lung cancer (NSCLC). Safety and tolerability will be measured by the number of dose-limi…
Phase: PHASE1 • Sponsor: Karen Reckamp, MD, MS • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC